Warfarin usage has been reported to be linked with improved overall survival in certain cancers, with growing evidence supporting its anti‐tumour effects via both blood plotting pathway‐dependent and independent mechanisms, the latter of which were evidenced in the inhibition of the Gas6‐AXL signalling.18, 46, 47. This evidence concerns the gene AXL and cancer.